These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7621594)

  • 21. Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin.
    Krause I; Blank M; Kopolovic J; Afek A; Goldberg I; Tomer Y; Shoenfeld Y
    J Rheumatol; 1995 Jun; 22(6):1068-74. PubMed ID: 7545755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of experimental systemic lupus erythematosus in mice by immunization with a monoclonal anti-La autoantibody.
    Fricke H; Offen D; Mendlovic S; Shoenfeld Y; Bakimer R; Sperling J; Mozes E
    Int Immunol; 1990; 2(3):225-30. PubMed ID: 2088487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of anti-idiotypic antibodies in the induction of experimental systemic lupus erythematosus in mice.
    Mendlovic S; Fricke H; Shoenfeld Y; Mozes E
    Eur J Immunol; 1989 Apr; 19(4):729-34. PubMed ID: 2659371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A peptide based on an anti-DNA autoantibody downregulates matrix metalloproteinases in murine models of lupus.
    Faber-Elmann A; Eilat E; Zinger H; Mozes E
    Clin Immunol; 2002 Nov; 105(2):223-32. PubMed ID: 12482397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A conserved anti-DNA antibody idiotype associated with nephritis in murine and human systemic lupus erythematosus.
    Weisbart RH; Noritake DT; Wong AL; Chan G; Kacena A; Colburn KK
    J Immunol; 1990 Apr; 144(7):2653-8. PubMed ID: 2319132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) patients.
    Mauermann N; Sthoeger Z; Zinger H; Mozes E
    Clin Exp Immunol; 2004 Sep; 137(3):513-20. PubMed ID: 15320900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulation of murine experimental SLE-like disease by interferon-gamma.
    Amital H; Levi Y; Blank M; Barak V; Langevitz P; Afek A; Nicoletti F; Kopolovic J; Gilburd B; Meroni PL; Shoenfeld Y
    Lupus; 1998; 7(7):445-54. PubMed ID: 9796846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFalpha monoclonal antibody and by pentoxiphylline.
    Segal R; Dayan M; Zinger H; Mozes E
    Lupus; 2001; 10(1):23-31. PubMed ID: 11243506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amelioration of experimental systemic lupus erythematosus (SLE) by retrovirus infection.
    Mittleman BB; Morse HC; Payne SM; Shearer GM; Mozes E
    J Clin Immunol; 1996 Jul; 16(4):230-6. PubMed ID: 8840225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of IL-12 on clinical and laboratory aspects of experimental SLE in young and aging mice.
    Segal R; Dayan M; Zinger H; Habut B; Shearer GM; Mozes E
    Exp Gerontol; 2003 Jun; 38(6):661-8. PubMed ID: 12814801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
    Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
    Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
    Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
    Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of early and late administration of M-20 derived interleukin-1 inhibitor on experimental systemic lupus erythematosus.
    Zandman-Goddard G; George J; Bland M; Levy Y; Yanai P; Halperin T; Shoenfeld Y; Barak V
    Immunol Lett; 1996 Nov; 53(2-3):77-82. PubMed ID: 9024982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of aging on cytokine production in normal and experimental systemic lupus erythematosus-afflicted mice.
    Dayan M; Segal R; Globerson A; Habut B; Shearer GM; Mozes E
    Exp Gerontol; 2000 Mar; 35(2):225-36. PubMed ID: 10767581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of experimental systemic lupus erythematosus with linomide.
    Zandman-Goddard G; George J; Levy Y; Blank M; Slavin S; Shoenfeld Y
    Lupus; 1996 Aug; 5(4):328-33. PubMed ID: 8869907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody.
    Waisman A; Ruiz PJ; Israeli E; Eilat E; Könen-Waisman S; Zinger H; Dayan M; Mozes E
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4620-5. PubMed ID: 9114040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The significance of experimental models of systemic lupus erythematosus and antiphospholipid syndrome induced by idiotypic manipulation.
    Shoenfeld Y
    Isr J Med Sci; 1994 Jan; 30(1):10-8. PubMed ID: 8138385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus.
    Miyawaki S; Nishiyama S; Aita T; Yoshinaga Y
    Mod Rheumatol; 2013 Jul; 23(4):659-66. PubMed ID: 23011357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies.
    Sthoeger ZM; Zinger H; Mozes E
    Ann Rheum Dis; 2003 Apr; 62(4):341-6. PubMed ID: 12634234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.